U.S. Markets closed

GenScript Launches Novel Coronavirus Detection Assay

Assay enables development of reliable molecular diagnostics for faster treatments and vaccines

PISCATAWAY, N.J., Jan. 30, 2020 /PRNewswire/ -- GenScript, the world's leading gene synthesis provider, today announced the commercial launch of an assay for detecting the Wuhan novel coronavirus (2019-nCoV). The fast, one-step 2019-nCoV quantitative reverse-transcription polymerase chain reaction (qRT-PCR) detection assay, or reagent, is designed to make it easier and faster to develop reliable molecular diagnostics to identify and treat the virus, and vaccines to ultimately prevent infection.

(PRNewsfoto/GenScript Biotech Corporation)

"Detecting the Wuhan virus in individuals can be difficult due to the long incubation period and the varying degree to which they are symptomatic," said Hong Li, Ph.D., GenScript's Department Head of Reagent Services, R&D Department. "We have been working diligently to develop this assay for the global community, and we are pleased to launch it in the United States following its initial release in China. With standard, reliable assays for diagnosing the infection, clinicians will be better equipped to treat and hopefully stop the spread of the infection and save lives."

GenScript's 2019-nCoV qRT-PCR detection assay is an enhancement on the World Health Organization's (WHO) monoplex protocol published earlier this month after the virus was identified in Wuhan city in the Hubei Province of China. GenScript has developed a multiplex protocol that can detect two to three genes in one reaction, therefore accelerating the detection time of all three genes associated with the virus. GenScript's production facility also has ISO13485 certification for oligo production to address the needs of the molecular diagnostic companies interested in developing kits for approval in the U.S. market.

Although several coronavirus detection kits have been approved in China under expedited review, the U.S. Food and Drug Administration has yet to approve a diagnostic assay. Molecular diagnostics use DNA to identify pathogens more quickly and accurately than traditional culture-based methods, and can be particularly critical in the field of infectious diseases.

In response to 2019-nCoV epidemic, GenScript also prioritized 2019-nCoV- related gene orders for research organizations developing vaccines or treatments for the deadly virus. A list of plasmids carrying useful genes related to virus detection and vaccine research are also avialible through Molecularcloud, a GenScript-operated reagent repository: https://www.molecularcloud.org/How-to-detect-the-2019-novel-coronavirus.html

As a pioneer and leader in gene synthesis technology with over 600,000 completed gene synthesis projects for scientists around the world, GenScript is committed to providing the best support to the research community and to advancing biomedical research.

Coronaviruses are a large family of viruses that are common in many different species of animals, including camels, cattle, cats, and bats. Rarely, animal coronaviruses can infect people and then spread between people such as with MERS and SARS. Chinese health authorities first identified cases of the novel Wuhan coronavirus, which has infected thousands in China and has spread to the U.S. and elsewhere internationally. The respiratory illness can be mild with cold-like symptoms or more severe, causing death often in people with underlying illnesses. More than 130 people have died to date.  

About GenScript

GenScript is the world leader in biotechnology reagent services and biologics. Established in 2002 in New Jersey, United States, the company was the first to commercialize gene synthesis and successfully establish fully integrated capabilities for custom peptide synthesis, protein expression and engineering, custom antibody development and engineering, in vitro/in vivo pharmacology as well as a variety of catalogue products. GenScript has now expanded its business into immunotherapy, CDMO, laboratory equipment, and the microbial industry to further fulfill its mission to make humans and nature healthier through biotechnology. GenScript has also established open and innovative technology-driven platforms and GMP facilities for pre-clinical drug discovery and pharmaceutical product development

Contacts
Corporate:
Eric Wang, vice president of marketing
GenScript
(732) 885-9188 ext. 131
ericw@genscript.com

Media
Susan Thomas
Principal, Endpoint Communications
(619) 540-9195
susan@endpointcommunications.net

Cision

View original content to download multimedia:http://www.prnewswire.com/news-releases/genscript-launches-novel-coronavirus-detection-assay-300996465.html

SOURCE Genscript Biotech Corporation

  • Business
    Barrons.com

    The Dow Dropped 1000 Points Monday. Here’s What History Says Happens Next.

    From a technical perspective, the S&P 500 should find support near its Jan. 31 low of 3225.52, according to Macro Risk Advisors' John Kolovos. That's right about where the S&P 500, at 3,225.89, closed, and if that breaks a full-blown correction is likely in play. This is the type of distributive selling that will require a good and proper reset in price, sentiment and or time on a break,” he writes.

  • Suze Orman says investors should ‘rejoice’ at the Dow’s more-than-1,000-point tumble — here’s why
    Business
    MarketWatch

    Suze Orman says investors should ‘rejoice’ at the Dow’s more-than-1,000-point tumble — here’s why

    Author and personal-finance expert Suze Orman had a simple two-word answer to the question of how to react to a market that just shed more than 1,000 points on the back of growing uncertainties, including the spread of the coronavirus outbreak. Orman said Monday on CNBC that investors should stay the course and explained why she thought investors worried about their retirement savings after a historic downturn for the Dow Jones Industrial Average should welcome such selloffs.

  • Dow Jones Futures Rebound After Tech Titans Lead Stock Market Rally Sell-Off
    Business
    Investor's Business Daily

    Dow Jones Futures Rebound After Tech Titans Lead Stock Market Rally Sell-Off

    Mastercard stock and Moderna stock moved overnight on coronavirus news, while Tandem Diabetes reported earnings. Apple stock, AMD stock, Tesla stock, Nvidia stock, Google stock, Amazon stock and Microsoft stock were big drags on the broader market. The Dow Jones Industrial Average, S&P 500 index and Nasdaq composite all fell below their 50-day moving averages, suffering their worst losses in more than a year.

  • Buffett is bullish on stocks but says the market can drop 50% — is he wrong?
    Business
    MarketWatch

    Buffett is bullish on stocks but says the market can drop 50% — is he wrong?

    Stock market investors are watching the coronavirus spreading far beyond China. It is no longer mostly in Asia. Italy has reported six coronavirus deaths and an accelerating number of cases.

  • The Dow tumbled more than 1,000 points and marked its third-worst point drop in history — here’s how the stock market tends to perform after big drops
    Business
    MarketWatch

    The Dow tumbled more than 1,000 points and marked its third-worst point drop in history — here’s how the stock market tends to perform after big drops

    The day's decline marks the third-biggest daily point drop for the Dow Jones Industrial Average (DJIA) in its 124-year history. To be sure, such point drops are less meaningful because the Dow has been trading at lofty levels. For example, the Dow's 1987 crash was a 508-point decline but that fall represented a 23% plunge back then.

  • Business
    NerdWallet

    How the IRS Knows If You Cheat on Your Taxes

    Those forms, called information returns, typically are records of certain payments you received or made during the tax year that you usually need to report on your tax return. Some of the most common information returns are W-2s, which report wages earned from a job, and 1099s, which report money received for things such as freelance work, dividends or interest. But other money moves you make could put information returns in the IRS' mailbox, too, says Ignatius Jackson, a certified public accountant in Phoenix.

  • Here are the worst-performing stocks Monday as investors panic over the coronavirus
    Business
    MarketWatch

    Here are the worst-performing stocks Monday as investors panic over the coronavirus

    a href="https://www.marketwatch.com/story/here-are-the-worst-performing-stocks-monday-as-investors-panic-over-the-coronavirus-2020-02-24? siteid=yhoof2" (UNH) -7.8% -5.5% -9.4% 18.0% American Express Co.

  • A pause after the plunge? U.S. stock futures rise, suggesting Tuesday gains
    Business
    MarketWatch

    A pause after the plunge? U.S. stock futures rise, suggesting Tuesday gains

    Stocks on Wall Street plunged Monday, but futures trading suggests a rebound — or a least a respite — on Tuesday. Dow Jones Industrial Average futures (YM00) rose more than 200 points at one point Monday, while S&P 500 futures (ES00) and Nasdaq Composite futures (NQ00) also posted gains of around 1% A pause or bounce-back would not be unusual. The past 10 times that the S&P 500 index fell by as much as 3%, for example, it declined just 0.27%, on average, in the next trading session, according to Dow Jones Market Data.

  • 'Flat earther' dies in rocket crash
    U.S.
    Associated Press Videos

    'Flat earther' dies in rocket crash

    A California man who said he wanted to fly to the edge of outer space to see if the world is round has died after his home-built rocket blasted off into the desert sky and plunged back to earth. Feb.

  • Gilead Surges After WHO Comments on Virus Drug Testing
    Business
    Bloomberg

    Gilead Surges After WHO Comments on Virus Drug Testing

    Gilead's compound, remdesivir, has been rushed into a clinical trial in China, where the illness has infected tens of thousands of people. Remdesivir is the “one drug right now that we think may have efficacy,” Bruce Aylward, an assistant director-general at the World Health Organization, said at a briefing in Beijing. Gilead shares rose 4.6% to $72.90 on Monday, the highest closing level since October 2018.

  • UnitedHealth stock plunges toward worst day in nearly 9 years as Sanders’ Nevada win stokes investor fear
    Politics
    MarketWatch

    UnitedHealth stock plunges toward worst day in nearly 9 years as Sanders’ Nevada win stokes investor fear

    Shares of UnitedHealth Group Inc. plunged toward their worst day in nearly 9 years Monday, as the narrative around a potential Bernie Sanders nomination may have swung to negative from positive following the senator's surprisingly big win in Nevada. Other health insurer stocks also took deeper dives than the broader stock market in afternoon trading. Shares of Centene Corp. (CNC) , which provides programs and services to government-sponsored health-care programs, plunged 10.2% to pace the 492 of 505 stocks on the S&P 500 index (SPX)  that were losing ground.

  • Why Fidelity 401(k) Millionaires Average $1.46 Mil Balances
    Business
    Investor's Business Daily

    Why Fidelity 401(k) Millionaires Average $1.46 Mil Balances

    The number of people with $1 million or more in 401(k) accounts in plans run by Fidelity Investments rose to a record 233,000. And the number of IRA millionaires — savers with balances of $1 million or more in accounts held at Fidelity — hit 208,000, also a record. Fidelity 401(k) Millionaire Traits In addition, Fidelity disclosed several of its 401(k) millionaires' traits: The average 401(k) balance for its millionaires reached $1,462,000.

  • Business
    Benzinga

    Warren Buffett On Monday's Market Plunge: 'That's Good For Us'

    Warren Buffett said in a CNBC interview Monday he prefers buying stocks at a cheaper price so Monday's sell-off is something "that's good for us." Buffett's annual chat with CNBC's Becky Quick coincided with a large sell-off in U.S. stocks as confirmed coronavirus cases are popping up in large numbers worldwide. But Buffett will be "buying on balance" and he "certainly won't" be selling any shares.

  • 4 Warren Buffett Holdings Trading Near 52-Week Lows
    Business
    GuruFocus.com

    4 Warren Buffett Holdings Trading Near 52-Week Lows

    According to current portfolio statistics, a Premium feature, four holdings of Warren Buffett (Trades, Portfolio)'s Berkshire Hathaway Inc. NYSE:BRK.A)(NYSE:BRK.B) are trading near 52-week lows on Monday as markets around the globe grapple with accelerating coronavirus fears: United Airlines Holdings Inc. NASDAQ:UAL), General Motors Co. (NYSE:GM), Synchrony Financial (NYSE:SYF) and The Travelers Companies Inc.

  • AMD Tests Support
    Business
    Investor's Business Daily Video

    AMD Tests Support

    AMD tumbled Monday, rebounding to close above 50-day line.

  • Exxon Drops to 15-Year Low Ahead of Annual Strategy Presentation
    Business
    Bloomberg

    Exxon Drops to 15-Year Low Ahead of Annual Strategy Presentation

    The shares have been under pressure since Exxon disclosed disappointing fourth-quarter results in late January and prospects for a near-term recovery were dimmed by the spreading coronavirus. Exxon fell 4.7% to close at $56.36 on Monday in New York as Brent crude tumbled to about $56 a barrel. Exxon has been scrutinizing employee-travel budgets since posting its worst quarterly profit in almost four years, people with knowledge of the matter told Bloomberg News earlier this month.

  • Markets ‘powered through’ SARS, but the coronavirus outbreak is different, Cowen says — and here’s why
    Business
    MarketWatch

    Markets ‘powered through’ SARS, but the coronavirus outbreak is different, Cowen says — and here’s why

    U.S. stocks may not be able to “power through” the coronavirus as they did with the SARS outbreak and the travel industry will take longer to recover, analysts at broker Cowen are warning. Global stocks tumbled on Monday as the spread of the coronavirus outside China intensified, with Italy and South Korea reporting a spike in new cases. The Dow Jones Industrial Average (DJIA) lost 760 points shortly after the open, and is now 1% down year-to-date, while the S&P (SPX) fell 2.5% in early trading and is 0.7% up so far in 2020.

  • Duke Energy, Williams Cos. and partners end the $1B Constitution Pipeline project
    Business
    American City Business Journals

    Duke Energy, Williams Cos. and partners end the $1B Constitution Pipeline project

    Duke Energy Corp. confirms that the four partners in the Constitution Pipeline have agreed to abandon the 124-mile project designed to carry natural gas from shale fields in Pennsylvania to New York and New England. “Although Constitution did receive positive outcomes in recent court proceedings and permit applications, the economics associated with this greenfield project have since changed in such a way that they no longer justify investment,” says Duke spokeswoman Tammie McGee. The delays and legal challenges have since driven up the costs by close to 40%.

  • Investors unable to access brokerage accounts as stocks fall — what you should know for your retirement accounts
    Business
    MarketWatch

    Investors unable to access brokerage accounts as stocks fall — what you should know for your retirement accounts

    Investors are advised not to change their investment portfolios when the market is volatile — some were forced to take that advice when they couldn't access their accounts Monday morning. Some Fidelity Investment users tweeted Monday morning that at the start of the trading day, they couldn't log in to their accounts, or when they did, they saw a $0 balance. This comes less than a week after Fidelity customers were unable to access their accounts, or came across with no balance for their 401(k) and other investment portfolios.

  • Business
    Barrons.com

    The Only 13 S&P 500 Stocks That Rose Today

    Monday was the worst day for the U.S. stock markets in two years. The S&P 500 index lost 3.4%, erasing its 2020 gains and more. All 11 of its sectors declined, led by energy's 4.6% drop.

  • India To Buy $3 Billion In U.S. Weapons But This Key Deal Awaits
    Politics
    Investor's Business Daily

    India To Buy $3 Billion In U.S. Weapons But This Key Deal Awaits

    President Donald Trump said India will sign $3 billion in military deals with the U.S. Tuesday, while Boeing and Lockheed Martin remain in a dogfight to win a massive fighter jet deal. Defense stocks dropped. Earlier this month, the State Department approved the sale of a Raytheon Integrated Air Defense Weapon System, which includes radars and missiles, to India as part of a $1.87 billion package.

  • J.P. Morgan: 2 “Strong Buy” Healthcare Stocks With Over 50% Upside
    Business
    TipRanks

    J.P. Morgan: 2 “Strong Buy” Healthcare Stocks With Over 50% Upside

    Digitization of the world we live in has disrupted the healthcare industry, giving rise to the healthcare information technology (IT) segment of the market. The emergence of this space and the technology it offers has transformed the way healthcare providers and organizations care for patients. Bearing this in mind, investing firm J.P. Morgan took a look at several healthcare IT names ahead of their upcoming fourth quarter earnings releases.

  • One of the market’s hottest stocks just bounced into the green to buck selloff
    Business
    MarketWatch

    One of the market’s hottest stocks just bounced into the green to buck selloff

    Virgin Galactic shares, which have been on a ridiculous tear lately, started Monday's session just like most stocks did — deep in the red. Yes, Richard Branson's Virgin Galactic (SPCE)saw its stock take a double-digit hit early, following the Dow Jones Industrial Average (DJIA)and the S&P 500 (SPX)into negative territory. But while the broader market failed to shake the coronavirus fears by the end of trading, Virgin Galactic, as you can see, caught a swarm of dip-buyers, who pushed the stock to a positive close on heavy volume.

  • Business
    Barrons.com

    Stock Trading Will Be Halted if the Market Falls Too Much. It Isn’t Even Close.

    Level One Breach A 7% decline in the S&P 500 from the prior day's close would trigger a so-called level one breach, where trading is halted for 15 minutes. That level on Monday is 3104.11. The S&P 500 closed at 3337.75 on Friday).

  • Why This Is The Only Marijuana Stock A Top Pot Analyst Still Rates As A Buy
    Business
    Investor's Business Daily

    Why This Is The Only Marijuana Stock A Top Pot Analyst Still Rates As A Buy

    Marijuana stocks fell Monday as Cowen downgraded Aurora Cannabis stock and Tilray, but kept Canopy Growth stock as its only "outperform" rating, amid ongoing supply and cash difficulties in Canada's legal recreational rollout and better prospects in the U.S. In a research note on Monday, Cowen analyst Vivien Azer said issues that have hurt the industry — too few stores to sell weed, difficulty bringing illicit-market customers into the legal market — "do not appear to be fading as anticipated." Newer legal products, like edibles and vapes, are "likely not the elixir that the market was hoping for," she said. Factoring those issues together, Cowen also slashed its full-year sales forecast by 32% to 3.5 billion Canadian dollars ($2.63 billion) in legal cannabis sales.